These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 21189318)

  • 21. The enterohemorrhagic Escherichia coli effector protein NleF binds mammalian Tmp21.
    Olsen RL; Echtenkamp F; Cheranova D; Deng W; Finlay BB; Hardwidge PR
    Vet Microbiol; 2013 May; 164(1-2):164-70. PubMed ID: 23434013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recruitment and membrane interactions of host cell proteins during attachment of enteropathogenic and enterohaemorrhagic Escherichia coli.
    Munera D; Martinez E; Varyukhina S; Mahajan A; Ayala-Sanmartin J; Frankel G
    Biochem J; 2012 Aug; 445(3):383-92. PubMed ID: 22587461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytoskeleton-modulating effectors of enteropathogenic and enterohemorrhagic Escherichia coli: role of EspL2 in adherence and an alternative pathway for modulating cytoskeleton through Annexin A2 function.
    Tobe T
    FEBS J; 2010 Jun; 277(11):2403-8. PubMed ID: 20477868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative proteomic analysis of type III secretome of enteropathogenic Escherichia coli reveals an expanded effector repertoire for attaching/effacing bacterial pathogens.
    Deng W; Yu HB; de Hoog CL; Stoynov N; Li Y; Foster LJ; Finlay BB
    Mol Cell Proteomics; 2012 Sep; 11(9):692-709. PubMed ID: 22661456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A type III effector antagonizes death receptor signalling during bacterial gut infection.
    Pearson JS; Giogha C; Ong SY; Kennedy CL; Kelly M; Robinson KS; Lung TW; Mansell A; Riedmaier P; Oates CV; Zaid A; Mühlen S; Crepin VF; Marches O; Ang CS; Williamson NA; O'Reilly LA; Bankovacki A; Nachbur U; Infusini G; Webb AI; Silke J; Strasser A; Frankel G; Hartland EL
    Nature; 2013 Sep; 501(7466):247-51. PubMed ID: 24025841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salmonella, E. coli, and Citrobacter Type III Secretion System Effector Proteins that Alter Host Innate Immunity.
    El Qaidi S; Wu M; Zhu C; Hardwidge PR
    Adv Exp Med Biol; 2019; 1111():205-218. PubMed ID: 30411307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamics of the type III secretion system activity of enteropathogenic Escherichia coli.
    Mills E; Baruch K; Aviv G; Nitzan M; Rosenshine I
    mBio; 2013 Jul; 4(4):. PubMed ID: 23900171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of the Inflammasome Signaling Pathway by Enteropathogenic and Enterohemorrhagic Escherichia coli.
    Yen H; Karino M; Tobe T
    Front Cell Infect Microbiol; 2016; 6():89. PubMed ID: 27617233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SepD/SepL-dependent secretion signals of the type III secretion system translocator proteins in enteropathogenic Escherichia coli.
    Deng W; Yu HB; Li Y; Finlay BB
    J Bacteriol; 2015 Apr; 197(7):1263-75. PubMed ID: 25645555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacterial Adrenergic Sensors Regulate Virulence of Enteric Pathogens in the Gut.
    Moreira CG; Russell R; Mishra AA; Narayanan S; Ritchie JM; Waldor MK; Curtis MM; Winter SE; Weinshenker D; Sperandio V
    mBio; 2016 Jun; 7(3):. PubMed ID: 27273829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamics of expression, secretion and translocation of type III effectors during enteropathogenic Escherichia coli infection.
    Serapio-Palacios A; Finlay BB
    Curr Opin Microbiol; 2020 Apr; 54():67-76. PubMed ID: 32058947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microbiota and Pathogen Proteases Modulate Type III Secretion Activity in Enterohemorrhagic Escherichia coli.
    Cameron EA; Curtis MM; Kumar A; Dunny GM; Sperandio V
    mBio; 2018 Dec; 9(6):. PubMed ID: 30514785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bringing down the host: enteropathogenic and enterohaemorrhagic Escherichia coli effector-mediated subversion of host innate immune pathways.
    Santos AS; Finlay BB
    Cell Microbiol; 2015 Mar; 17(3):318-32. PubMed ID: 25588886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Here, there, and everywhere: How pathogenic Escherichia coli sense and respond to gastrointestinal biogeography.
    Woodward SE; Krekhno Z; Finlay BB
    Cell Microbiol; 2019 Nov; 21(11):e13107. PubMed ID: 31454133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CRISPR Screen Reveals that EHEC's T3SS and Shiga Toxin Rely on Shared Host Factors for Infection.
    Pacheco AR; Lazarus JE; Sit B; Schmieder S; Lencer WI; Blondel CJ; Doench JG; Davis BM; Waldor MK
    mBio; 2018 Jun; 9(3):. PubMed ID: 29921669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Citrobacter rodentium translocated intimin receptor (Tir) is an essential virulence factor needed for actin condensation, intestinal colonization and colonic hyperplasia in mice.
    Deng W; Vallance BA; Li Y; Puente JL; Finlay BB
    Mol Microbiol; 2003 Apr; 48(1):95-115. PubMed ID: 12657048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral Administration with Live Attenuated Citrobacter rodentium Protects Immunocompromised Mice from Lethal Infection.
    Wang S; Xia X; Liu Y; Wan F
    Infect Immun; 2022 Jul; 90(7):e0019822. PubMed ID: 35861565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The bacterial arginine glycosyltransferase effector NleB preferentially modifies Fas-associated death domain protein (FADD).
    Scott NE; Giogha C; Pollock GL; Kennedy CL; Webb AI; Williamson NA; Pearson JS; Hartland EL
    J Biol Chem; 2017 Oct; 292(42):17337-17350. PubMed ID: 28860194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of NF-κB signaling in human dendritic cells by the enteropathogenic Escherichia coli effector protein NleE.
    Vossenkämper A; Marchès O; Fairclough PD; Warnes G; Stagg AJ; Lindsay JO; Evans PC; Luong le A; Croft NM; Naik S; Frankel G; MacDonald TT
    J Immunol; 2010 Oct; 185(7):4118-27. PubMed ID: 20833837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tandem tyrosine phosphosites in the Enteropathogenic Escherichia coli chaperone CesT are required for differential type III effector translocation and virulence.
    Runte CS; Jain U; Getz LJ; Secord S; Kuwae A; Abe A; LeBlanc JJ; Stadnyk AW; Kaper JB; Hansen AM; Thomas NA
    Mol Microbiol; 2018 Jun; 108(5):536-550. PubMed ID: 29509331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.